Nuclear factor kappa B (NF-kappaB) regulates proinflammatory genes and may
be involved in inflammation associated with reproductive events e,g. menstr
uation, implantation. Activation of NF-kappaB involves several protein kina
ses and subsequent degradation of an endogenous inhibitor, I kappaB alpha,
This study details expression of NF-kappaB pathway intermediates in human e
ndometrium and first trimester decidua, Messenger RNA was detected for I ka
ppaB alpha, and I kappaB kinase gamma (IKK gamma, a scaffolding protein) an
d the protein kinases, IKK alpha, IKK beta, NF-kappaB inducing kinase (NIK)
, mitogenactivated protein kinase Erk kinase kinase 1 (MEKK1) and TANK-bind
ing kinase 1 (TBK1) using real-time quantitative polymerase chain reaction
(PCR), I kappaB alpha and TBK1 mRNA were increased in the perimenstrual pha
se of the menstrual cycle, This suggests that there is activation of NF-kap
paB due to premenstrual progesterone withdrawal, since NF-kappaB activity i
ncreases I kappaB alpha gene expression. Differential expression of NF-kapp
aB pathway intermediates occurred when progesterone concentrations increase
d in early pregnancy; IKK alpha and NIK mRNA levels increased in decidua wh
ilst IKK beta and MEKK1 mRNA levels declined. Expression profiles of IKK al
pha and NIK proteins were determined immunohistochemically. Both were detec
ted in glandular epithelium and endothelium of endometrium, In decidua, bot
h were present in epithelium and decidualized stromal cells. The results of
this study suggest that NF-kappaB is activated during menstruation. During
early pregnancy, NF-kappaB may also be activated (via IKK alpha -NIK) and
may regulate the expression of molecules vital for implantation and success
ful pregnancy. However, proinflammatory signalling to NF-kappaB (via IKK be
ta -MEKK1) may be down-regulated in early pregnancy, contributing to the im
munosuppressive mechanisms which prevail at this time.